« Live from Mars.... it's Themis | Main | Bye-bye-biotech industry? »

Bookmark in Connotea

On Nature News - March 17, 2009

Big interest in heavy drugs
The drug industry is seeking profits by modifying hydrogen in existing medications.

Incoming chief to tackle woes of US food and drug agency
Obama nominates Margaret 'Peggy' Hamburg as FDA chief.

US agencies brace for flood of grant applications
Online system has high risk of failure, officials say.

European clinical trial rules under fire
European medical research strangled by red tape, scientists warn.

Posted by Daniel Cressey on March 17, 2009
Categories: On Nature News | | Comments (0) | TrackBacks (0)

Post a comment

Comments will be reviewed by the blog editors before being published, mainly to ensure that spam and irrelevant material (such as product advertisements) are not published . Please keep your comment brief. Excessively long or offensively phrased entries will be edited.

We strongly encourage you to use your real, full name. E-mail addresses are required in case we need to discuss your comment with you directly. We won't publish your e-mail address unless you request it.

Please enter the numbers you see below - this helps us to cut down on spam. Note that attempting to post within 30 seconds of hitting ‘preview’ or ‘post’ can cause the system to think you are spamming the site. If you are having trouble with this system, you can instead e-mail a comment to 'thegreatbeyond at nature.com'.

please enter code

TrackBack

TrackBack URL for this entry:
http://blogs.nature.com/cgi-bin/mt/mt-tb.cgi/7696